Home Cart 0 Sign in  
X

[ CAS No. 67832-11-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 67832-11-5
Chemical Structure| 67832-11-5
Chemical Structure| 67832-11-5
Structure of 67832-11-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 67832-11-5 ]

Related Doc. of [ 67832-11-5 ]

Alternatived Products of [ 67832-11-5 ]

Product Details of [ 67832-11-5 ]

CAS No. :67832-11-5 MDL No. :MFCD00041461
Formula : C8H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :LPEBMDFRIKYFCF-UHFFFAOYSA-N
M.W : 196.04 Pubchem ID :144267
Synonyms :

Calculated chemistry of [ 67832-11-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.82
TPSA : 23.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.18
Log Po/w (XLOGP3) : 2.7
Log Po/w (WLOGP) : 2.63
Log Po/w (MLOGP) : 2.52
Log Po/w (SILICOS-IT) : 2.94
Consensus Log Po/w : 2.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.2
Solubility : 0.124 mg/ml ; 0.00063 mol/l
Class : Soluble
Log S (Ali) : -2.85
Solubility : 0.275 mg/ml ; 0.0014 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.73
Solubility : 0.0368 mg/ml ; 0.000188 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 67832-11-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H302-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 67832-11-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 67832-11-5 ]
  • Downstream synthetic route of [ 67832-11-5 ]

[ 67832-11-5 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 67832-11-5 ]
  • [ 64169-34-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 754 - 763
  • 2
  • [ 583-71-1 ]
  • [ 6941-75-9 ]
  • [ 623-00-7 ]
  • [ 67832-11-5 ]
  • [ 70484-01-4 ]
Reference: [1] Russian Journal of General Chemistry, 2010, vol. 80, # 8, p. 1672 - 1676
[2] Russian Journal of General Chemistry, 2014, vol. 84, # 6, p. 1085 - 1090
  • 3
  • [ 67832-11-5 ]
  • [ 6941-75-9 ]
  • [ 124-38-9 ]
  • [ 623-00-7 ]
  • [ 70484-01-4 ]
Reference: [1] Russian Journal of General Chemistry, 2013, vol. 83, # 3, p. 492 - 495[2] Zh. Obshch. Khim., 2013, vol. 83, # 3, p. 439 - 442,4
  • 4
  • [ 67832-11-5 ]
  • [ 86-90-8 ]
Reference: [1] Chemische Berichte, 1887, vol. 20, p. 1017
  • 5
  • [ 67832-11-5 ]
  • [ 14143-26-1 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 3, p. 708 - 711
  • 6
  • [ 67832-11-5 ]
  • [ 124-41-4 ]
  • [ 21883-13-6 ]
Reference: [1] European Journal of Organic Chemistry, 2015, vol. 2015, # 22, p. 4922 - 4930
  • 7
  • [ 67832-11-5 ]
  • [ 68837-59-2 ]
YieldReaction ConditionsOperation in experiment
60% With potassium hydroxide In waterReflux 4-bromo-2-methylbenzonitrile (1 mmol) was suspended in water (49 mL) and potassium hydroxide was added (50 mmol); the reaction mixture was stirred at reflux overnight. After cooling, the basic solution was washed with ethyl acetate (3 x 15 mL), acidified with hydrochloric acid (6M) and extracted with ethyl acetate (3 x 15 mL). The organic phase deriving from the acidic extraction was dried over anhydrous sodium sulfate and concentrated in vacuo, yielding the desired product as a white solid. Yield: 60percent. TLC (dichloromethane – methanol 9:1): Rf = 0.46. Mp: 182°C. 1H-NMR (300 MHz, CD3OD) δ (ppm) 7.80 (d, J = 8.4 Hz, 1H, H6), 7.48 (s, 1H, H3), 7.42 (d, J = 8.4 Hz, 1H, H5), 2.56 (s, 3H, CH3).
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 754 - 763
[2] Chemische Berichte, 1887, vol. 20, p. 1017
[3] Journal fuer Praktische Chemie (Leipzig), 1889, vol. <2> 39, p. 486
[4] Chemische Berichte, 1887, vol. 20, p. 1017
[5] Journal fuer Praktische Chemie (Leipzig), 1889, vol. <2> 39, p. 486
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5936 - 5940
  • 8
  • [ 67832-11-5 ]
  • [ 24078-12-4 ]
Reference: [1] Patent: WO2008/729, 2008, A1, . Location in patent: Page/Page column 86-87
[2] Patent: CN102516115, 2016, B, . Location in patent: Paragraph 0602-0604; 0606-0608
  • 9
  • [ 89001-53-6 ]
  • [ 67832-11-5 ]
Reference: [1] Journal of Organic Chemistry, 1962, vol. 27, p. 1426 - 1430
  • 10
  • [ 99-52-5 ]
  • [ 67832-11-5 ]
Reference: [1] Journal of Organic Chemistry, 1962, vol. 27, p. 1426 - 1430
  • 11
  • [ 583-71-1 ]
  • [ 6941-75-9 ]
  • [ 623-00-7 ]
  • [ 67832-11-5 ]
  • [ 70484-01-4 ]
Reference: [1] Russian Journal of General Chemistry, 2010, vol. 80, # 8, p. 1672 - 1676
[2] Russian Journal of General Chemistry, 2014, vol. 84, # 6, p. 1085 - 1090
  • 12
  • [ 72115-06-1 ]
  • [ 67832-11-5 ]
Reference: [1] Journal of Organic Chemistry, 1962, vol. 27, p. 1426 - 1430
  • 13
  • [ 583-75-5 ]
  • [ 67832-11-5 ]
Reference: [1] Chemische Berichte, 1887, vol. 20, p. 1017
[2] Journal fuer Praktische Chemie (Leipzig), 1889, vol. <2> 39, p. 486
  • 14
  • [ 67832-11-5 ]
  • [ 99548-55-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5936 - 5940
  • 15
  • [ 67832-11-5 ]
  • [ 72115-06-1 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 43, p. 5625 - 5628
  • 16
  • [ 124-38-9 ]
  • [ 67832-11-5 ]
  • [ 73831-13-7 ]
YieldReaction ConditionsOperation in experiment
73%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at -78 - 20℃;
Stage #3: With hydrogenchloride In water
To a solution of 4-bromo-2-methylbenzonitrile (2.0 g, 10.2 mmol) in THF (100 ml) at -78°C under a nitrogen atmosphere was added dropwise a 2.5 M solution of n-butyl lithium (4.48 ml, 11.2 mmol). The mixture was stirred at -78°C for 1h and then poured onto solid carbon dioxide (5 g) in THF (50 ml). The mixture was allowed to warm to room temperature. Water was added (200 ml) and the mixture was extracted with diethyl ether (3 times). The aqueous layer was acidified by addition of concentrated HCl and extracted with chloroform (3 times). The combined chloroform extracts were washed with water, dried over MgSO4, and concentrated in vacuo to give a white solid identified as 4-cyano-3-methylbenzoic acid (1.2 g, 73percent).
73%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at 20℃;
Example B
4-Cyano-3-methylbenzoic acid
To a solution of 4-bromo-2-methylbenzonitrile (2.0g, 10.2mmol) in THF (100ml) at -78°C under a nitrogen atmosphere was added dropwise a 2.5M solution of n-butyl lithium (4.48ml, 11.2mmol).
The mixture was stirred at -78°C for 1h and then poured onto solid carbon dioxide (5g) in THF (50ml).
The mixture was allowed to warm to room temperature.
Water was added (200ml) and the mixture was extracted with diethyl ether (3 times).
The aqueous layer was acidified by addition of concentrated HCl and extracted with chloroform (3 times).
The combined chloroform extracts were washed with water, dried over MgSO4, and concentrated in vacuo to give a white solid identified as 4-cyano-3-methylbenzoic acid (1.2g, 73percent).
73%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at 20℃;
To a solution of 4-bromo-2-methylbenzonitrile (2.0g, 10.2mmol) in THF (100ml) at -78°C under a nitrogen atmosphere was added dropwise a 2.5M solution of n-butyl lithium (4.48ml, 11.2mmol). The mixture was stirred at -78°C for lh and then poured onto solid carbon dioxide (5g) in THF (50ml). The mixture was allowed to warm to room temperature. Water was added (200ml) and the mixture was extracted with diethyl ether (3 times). The aqueous layer was acidified by addition of concentrated HC1 and extracted with chloroform (3 times). The combined chloroform extracts were washed with water, dried over MgS04, and concentrated in vacuo to give a white solid; yielding (73percent).
73%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at -78 - 20℃;
Stage #3: With water In tetrahydrofuran; water
To a solution of 4-bromo-2-methylbenzonitrile (2.0 g, 10.2 mmol) in THF (100 ml) at -78° C. under a nitrogen atmosphere was added dropwise a 2.5M solution of n-butyl lithium (4.48 ml, 11.2 mmol)..
The mixture was stirred at -78° C. for 1 h and then poured onto solid carbon dioxide (5 g) in THF (50 ml)..
The mixture was allowed to warm to room temperature..
water was added (200 ml) and the mixture was extracted with diethyl ether (3 times)..
The aqueous layer was acidified by addition of concentrated HCl and extracted with chloroform (3 times)..
The combined chloroform extracts were washed with water, dried over MgSO4, and concentrated in vacuo to give a white solid; yield 1.2 g (73percent).
64%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at 20℃;
Asolution of nBuLi in THF (2.5 M, 4.49 mL, 11.2 mmol) was added dropwise to astirred solution of 4-bromo-2-methylbenzonitrile (2.0 g,10.2 mmol) in dry THF (100 mL) at −78° C. and the solution stirred at −78° C.for 1 h. A stream of dry CO2 was bubbled through the solution for 10 min andthe mixture warmed to 20° C. The mixture was diluted with water (100 ml) andwashed with Et2O (3×20 mL). The aqueous phase was acidified to pH 2 with cHCland extracted with CHCl3 (3×50 mL) and the organic fraction was dried and thesolvent evaporated to give crude acid 171 (1.05 g, 64percent)
60.8%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5 h; Inert atmosphere
Stage #2: at -78 - 20℃; for 1 h; Inert atmosphere
Stage #3: With hydrogenchloride In water; ethyl acetate
A solution of 2.5 M n-butyllithium in hexanes(6.7 mL, 16.8 mmol) was added to anhydrous THF (15 mL) at −78 °C. A solution of 4-bromo-2-methylbenzonitrile 21 (3.0 g, 15.3 mmol) in THF (15 mL) was then added dropwise and allowed to stir for 30 min. Dry ice (solid CO2) was added and the solution was allowed to stir 1 h while warming to room temperature. The reaction was then concentrated in vacuo and the resulting residue was triturated in ether and filtered. The solid was dissolved in EtOAc and washed with 2 M HCl and brine. The organic layer was isolated, dried over MgSO4, concentrated in vacuo, then triturated in ether/ hexane and dried under high vacuum. Obtained 4-cyano-3-methylbenzoic acid 22 (1.5 g, 60.8percent yield) as a white solid. 1H NMR (400 MHz, CDCl3) δ (ppm) 8.18 (s, 1H), 8.02–8.09 (m, 1H), 7.75–7.81 (m, 1H), 2.61 (s, 3H).
34%
Stage #1: With n-butyllithium In tetrahydrofuran; hexanes at -78℃; Inert atmosphere
Stage #2: at 20℃;
Stage #3: With hydrogenchloride In water
To a -780C cooled solution of 4-bromo-2-methylbenzonitrile (4.00 g, 20.40 mmol) in THF (200 mL) under nitrogen atmosphere, 2.5M solution of n-BuLi in hexanes (10 ml_, 25 mmol) was slowly added and the resulting solution left to stir at -780C for 1 hour. This solution was slowly poured into a mixture of solid CO2 (10 g) in THF (100 mL) and it was stirred at room temperature overnight. The solvent was concentrated in vaccuo, water was added, it was extracted with diethyl ether (x 3) and the aqueous phase was acidified with 5N hydrochloric acid. The solid was filtered and dried to yield 1.11 g (34percent yield) of the title compound.LRMS: m/z 160(M-I )-Retention time: 4.82min (method B)

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 17, p. 4585 - 4589
[2] Patent: EP1449844, 2004, A1, . Location in patent: Page 21
[3] Patent: EP1512687, 2005, A1, . Location in patent: Page/Page column 7
[4] Patent: WO2006/18443, 2006, A1, . Location in patent: Page/Page column 21
[5] Patent: US6664249, 2003, B1, . Location in patent: Page column 11
[6] Patent: JP5789603, 2015, B2, . Location in patent: Paragraph 0346
[7] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 7, p. 1880 - 1897
[8] Patent: WO2014/127350, 2014, A1, . Location in patent: Page/Page column 146
[9] Patent: WO2010/43377, 2010, A1, . Location in patent: Page/Page column 89
[10] Journal of Medicinal Chemistry, 2008, vol. 51, # 24, p. 8124 - 8134
  • 17
  • [ 67832-11-5 ]
  • [ 73831-13-7 ]
YieldReaction ConditionsOperation in experiment
73% With hydrogenchloride; n-butyllithium In tetrahydrofuran; water EXAMPLE B
4-Cyano-3-methylbenzoic acid
To a solution of 4-bromo-2-methylbenzonitrile (2.0 g, 10.2 mmol) in THF (100 ml) at -78° C. under a nitrogen atmosphere was added dropwise a 2.5M solution of n-butyl lithium (4.48 ml, 11.2 mmol).
The mixture was stirred at -78° C. for 1 h and then poured onto solid carbon dioxide (5 g) in THF (50 ml).
The mixture was allowed to warm to room temperature.
Water was added (200 ml) and the mixture was extracted with diethyl ether (3 times).
The aqueous layer was acidified by addition of concentrated HCl and extracted with chloroform (3 times).
The combined chloroform extracts were washed with water, dried over MgSO4, and concentrated in vacuo to give a white solid; yield 1.2 g (73percent).
73% With hydrogenchloride; n-butyllithium In tetrahydrofuran; water Example C
4Cyano-3methylbenzoic acid
To a solution of 4bromo-2-methylbenzonitrile (2.0 g, 10.2 mmol) in THF (100 ml) at -78° C. under a nitrogen atmosphere was added dropwise a 2.5M solution of n-butyl lithium (4.48 ml, 11.2 mmol).
The mixture was stirred at -78° C. for 1 h and then poured onto solid carbon dioxide (5 g) in THF (50 ml).
The mixture was allowed to warm to room temperature.
Water was added (200 ml) and the mixture was extracted with diethyl ether (3 times).
The aqueous layer was acidified by addition of concentrated HCl and extracted with chloroform (3 times).
The combined chloroform extracts were washed with water, dried over MgSO4, and concentrated in vacuo to give a white solid; yield 1.2 g (73percent).
Reference: [1] Patent: US2003/87892, 2003, A1,
[2] Patent: US2004/38962, 2004, A1,
  • 18
  • [ 109-72-8 ]
  • [ 67832-11-5 ]
  • [ 73831-13-7 ]
Reference: [1] Patent: US5883102, 1999, A,
  • 19
  • [ 583-71-1 ]
  • [ 6941-75-9 ]
  • [ 623-00-7 ]
  • [ 67832-11-5 ]
  • [ 70484-01-4 ]
Reference: [1] Russian Journal of General Chemistry, 2010, vol. 80, # 8, p. 1672 - 1676
[2] Russian Journal of General Chemistry, 2014, vol. 84, # 6, p. 1085 - 1090
  • 20
  • [ 67832-11-5 ]
  • [ 6941-75-9 ]
  • [ 124-38-9 ]
  • [ 623-00-7 ]
  • [ 70484-01-4 ]
Reference: [1] Russian Journal of General Chemistry, 2013, vol. 83, # 3, p. 492 - 495[2] Zh. Obshch. Khim., 2013, vol. 83, # 3, p. 439 - 442,4
  • 21
  • [ 67832-11-5 ]
  • [ 376646-62-7 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With borane In tetrahydrofuran at 0 - 80℃; Inert atmosphere
Stage #2: With hydrogenchloride In 1,4-dioxane; ethyl acetate for 0.0833333 h;
[0617j To a solution of 4-bromo-2-methylbenzonitrile (3.0 g, 15 mmol) in anhydrous THF (20 mL) under nitrogen at 0 °C was added 1.0 M solution of borane in THF (46 mL). The reaction mixture was stirred at 0 °C for 1 h, and heated at 80 °C overnight. The reaction mixture was cooled to 0 °C and slowly quenched with MeOH, concentrated in vacuo. The crude product was treated with EtOAc (20 mL) and 4 M of HC1 in 1,4-dioxane (8.0 mL, 32 mmol) for 5 mm. The solid was filtered, rinsed with diethyl ether, dried to give the title compound as a white powder (3.24 g, yield: 100percent). LCMS: RT 0.75 mm.; MH+ 200.0. ‘H NMR (300 MHz, DMSOd6) 5: 8.28 (br. s., 2H), 7.42 - 7.54 (m, 2H), 7.34 (d, J = 7.93 Hz, 1H), 3.99 (d, J = 4.15 Hz, 2H), 2.35 (s, 3H).
90% With THF·BF3 In tetrahydrofuran at 0 - 80℃; for 17 h; [0114] To a solution of 4-bromo-2-methylbenzonitrile (3 g, 15 mmol) in THF (20 mL), BH3 THF (45 mL, 45 mmol) was added. The solution was stirred at 0 °C for 1 h and heated to 80 °C for 16 h. Then the mixture was quenched with MeOH. After concentrated, the residue was stirred with saturated HCl/EtOAc solution and filtered. The filter cake was rinsed with ether (20 mL x3) and dried under vacuum to afford (4-bromo-2-methylphenyl)methanamine (3.2 g, yield: 90percent) as white solid. ESI-MS (M+H)+: 200.1 Preparation of tert-butyl 4-bromo-2-methylbenzylcarbamate
69% With borane-THF In tetrahydrofuran at 0 - 80℃; for 3 h; To a solution of 4-bromo-2-methylbenzonitrile (3 g, 15 mmol) in THF (20 mL) was added BH3·THF (45 mL, 45 mmol) at 0 °C. The solution was stirred for 1 h and heated to 80 °C for 2 h. The mixture was quenched with H2O and extracted with EtOAc (50 mL x 3). The organic layer was concentrated in vacuo to afford a residue which was suspended in saturated HCl/EtOAc and filtered. The filter cake was washed with diethyl ether (20 mL x 3) and dried under vacuum to afford the desired product (2.1 g, yield 69percent) as white solid. ESI-MS (M+H)+: 200.1.
Reference: [1] Patent: WO2015/89337, 2015, A1, . Location in patent: Paragraph 0617
[2] Patent: WO2016/201271, 2016, A1, . Location in patent: Paragraph 0114
[3] Patent: WO2015/89327, 2015, A1, . Location in patent: Paragraph 0195
  • 22
  • [ 67832-11-5 ]
  • [ 713141-12-9 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 23, p. 6086 - 6089
  • 23
  • [ 67832-11-5 ]
  • [ 1171381-49-9 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: With borane-THF In tetrahydrofuran at 0 - 80℃; for 17 h;
Stage #2: With hydrogenchloride In ethyl acetate
To a solution of 4-bromo-2-methylbenzonitrile (3 g, 15 mmol) in THF (20 mL),BH3THF (45 mL, 45 mmol) was added. The solution was stirred at 0 °C for 1 h and heated to 80°C for 16 h. Then the mixture was quenched with MeOH. After concentrated, the residue wasstirred with saturated HC1/EtOAc solution and filtered. The filter cake was rinsed with ether (20mL x3) and dried under vacuum to afford (4-bromo-2-methylphenyl)methanamine (3.2 g, yield:90percent) as white solid. ESI-MS (M+H) : 200.1
Reference: [1] Patent: WO2016/201280, 2016, A1, . Location in patent: Paragraph 0655; 0656
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 67832-11-5 ]

Aryls

Chemical Structure| 925672-88-4

[ 925672-88-4 ]

5-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 6952-59-6

[ 6952-59-6 ]

3-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 623-00-7

[ 623-00-7 ]

4-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 77532-78-6

[ 77532-78-6 ]

2-Bromo-6-methylbenzonitrile

Similarity: 0.92

Bromides

Chemical Structure| 925672-88-4

[ 925672-88-4 ]

5-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 6952-59-6

[ 6952-59-6 ]

3-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 623-00-7

[ 623-00-7 ]

4-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 77532-78-6

[ 77532-78-6 ]

2-Bromo-6-methylbenzonitrile

Similarity: 0.92

Nitriles

Chemical Structure| 925672-88-4

[ 925672-88-4 ]

5-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.95

Chemical Structure| 6952-59-6

[ 6952-59-6 ]

3-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 623-00-7

[ 623-00-7 ]

4-Bromobenzonitrile

Similarity: 0.94

Chemical Structure| 77532-78-6

[ 77532-78-6 ]

2-Bromo-6-methylbenzonitrile

Similarity: 0.92